Life Science Outsourcing, Inc.

Life Science Outsourcing, Inc. provides specialized manufacturing services for medical devices and implants, ensuring compliance with FDA regulations and ISO 13485 standards through tailored solutions. Founded in 1997 by Barry Kazemi, Life Science Outsourcing, Inc. operates from its headquarters in Brea, California, US.

The company focuses on manufacturing services for medical devices and has undergone strategic pivots to enhance operational efficiency. As of January 25, 2021, Public Pension Capital Management acquired a majority stake in the firm, although financial terms were not disclosed. Life Science Outsourcing specializes in a comprehensive range of manufacturing services for medical devices and implants. Their offerings include cleanroom assembly, packaging, labeling, sterilization, and validated cleaning and inspection services designed for both reusable and single-use medical devices.

The company serves a diverse clientele, including medical device manufacturers and healthcare organizations, across North America, Europe, and Asia, ensuring compliance with specific regulatory standards. Life Science Outsourcing generates revenue primarily through contract manufacturing agreements, providing services such as assembly, sterilization, and compliance testing to a variety of clients, from small startups to large healthcare corporations. Their revenue model is structured around business-to-business transactions, where pricing plans are tailored to accommodate the complexity and scale of projects, reflecting a range of fixed and variable pricing. Key services include sterilization methods such as EtO, Gamma, E-Beam, and Steam, along with extensive package testing to ensure conformity with ISO 11607 and FDA guidelines.

Life Science Outsourcing is focusing on expanding its product offerings, with several new services in development for launch in the upcoming year. The company aims to penetrate new markets, particularly in Asia and Europe, by the end of 2023. The investment from Public Pension Capital Management will support these initiatives by enhancing production capabilities and facilitating market entry strategies.